Evidence map›Paper›PMID 40083938›Full record

ArticleTheranostics2025

7-nm Mn

Joo Young Lee, Yi Rang Na, Chul Min Na, Pyung Won Im, Hyung Woo Park, Min Kyu Kim, Yona Kim, Ji Hyeon You, Dong Su Kang, Hyo Eun Moon and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Joo Young LeeDepartment of Neurosurgery, Cancer Research Institute, Seoul National University College of Medicine. Seoul 03080, Republic of Korea.
Yi Rang NaTranslational Immunology Lab, Department of Transdisciplinary Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea.
Chul Min NaDepartment of Neurosurgery, Cancer Research Institute, Seoul National University College of Medicine. Seoul 03080, Republic of Korea.
Pyung Won ImDepartment of Neurosurgery, Cancer Research Institute, Seoul National University College of Medicine. Seoul 03080, Republic of Korea.
Hyung Woo ParkDepartment of Neurosurgery, Cancer Research Institute, Seoul National University College of Medicine. Seoul 03080, Republic of Korea.
Min Kyu KimDepartment of Neurosurgery, Cancer Research Institute, Seoul National University College of Medicine. Seoul 03080, Republic of Korea.
Yona KimDepartment of Neurosurgery, Cancer Research Institute, Seoul National University College of Medicine. Seoul 03080, Republic of Korea.
Ji Hyeon YouDepartment of Neurosurgery, Cancer Research Institute, Seoul National University College of Medicine. Seoul 03080, Republic of Korea.
Dong Su KangTranslational Immunology Lab, Department of Transdisciplinary Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea.
Hyo Eun MoonDepartment of Neurosurgery, Cancer Research Institute, Seoul National University College of Medicine. Seoul 03080, Republic of Korea.
Hye Ran ParkDepartment of Neurosurgery, Soonchunhyang University Seoul Hospital, Seoul 04401, Republic of Korea.
Min Gyu KimPohang Accelerator Laboratory (PAL) Pohang 37673, Republic of Korea.
Pilhan KimGraduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.
Sung Hye ParkDepartment of Pathology, Neuroscience Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Hye Won YounDepartment of Nuclear Medicine, Seoul National University Hospital, Republic of Korea. Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Republic of Korea.
Young Don SonDepartment of Biomedical Engineering, Gachon University, Seongnam, Republic of Korea.
Yasushi TakemuraDepartment of Electrical and Computer Engineering, Yokohama National University Yokohama 240-8501, Japan.
Chang Won SongDepartment of Radiation Oncology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Daishun LingFrontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, School of Biomedical Engineering, National Center for Translational Medicine, State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University, 200240, Shanghai, China; World Laureates Association (WLA) Laboratories, 201203, Shanghai, China.
Yuanzhe PiaoDepartment of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Seoul National University, Seoul 08826, Republic of Korea. Advanced Institutes of Convergence Technology, Suwon-si, Gyeonggi-do, Republic of Korea.
Sun Ha PaekDepartment of Neurosurgery, Cancer Research Institute, Seoul National University College of Medicine. Seoul 03080, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Superparamagnetic iron oxide nanoparticles (SPIONs) are promising contrast agents for imaging-guided cancer therapies. However, challenges such as the requirement for a high alternating magnetic field (AMF), dosage limitations, and suboptimal imaging contrast have hindered their practical applications.

Indexed as

Hyperthermia, InducedMagnetic Iron Oxide NanoparticlesMagnetic Resonance ImagingTheranostic NanomedicineAnimalsContrast MediaFerric CompoundsHumansManganeseMiceZincContrast MediaFerric CompoundsManganeseZincalternating magnetic fields (AMFs)glioblastomamagnetic hyperthermiaMn0.5Zn0.5Fe2O4superparamagnetic iron oxide nanoparticle (SPION)

Identifiers

PMID40083938
PMCPMC11898280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.